Introduction
Polygonum minus (Pm) or 'kesum' in Malaysia, is used as a flavouring ingredient in local dishes such as 'laksa' and 'asam pedas' [1] . It is originated from Southeast Asia countries especially Malaysia, Indonesia and Thailand [2] . It grows wildly in damp and Objective: To explore the protective effect of Polygonum minus ethanolic extract on cisplatininduced neurotoxicity. Methods: In vitro test, total phenolic content assay and DPPH assay were performed to determine the antioxidant activity of Polygonum minus. For in vivo test, 30 male SpragueDawley rats were randomly divided into 5 groups: the control group, cisplatin 10 mg/kg, Polygonum minus 100 mg/kg, Polygonum minus 200 mg/kg and Polygonum minus 400 mg/kg. The control group and the cisplatin group were given distilled water whereas Polygonum minus groups received the respective dose of Polygonum minus extract orally for 14 d. On day 15, a single intraperitoneal administration of normal saline was given to the control group; while 10 mg/kg of cisplatin was given to the cisplatin group and Polygonum minus groups. Body weight, signs of illness, daily activity and mortality were observed at least once daily throughout the experimental period. On day 18, the anterior part of the brain was collected and processed for histological and ultrastructural analyses (right hemisphere). The remaining part (left hemisphere) of the brain was assayed to determine malondialdehyde and catalase levels for oxidative stress analyses. Results: Polygonum minus ethanolic extract possessed high phenolic content (977.6 mg GAE/g) and 95.9% DPPH radical scavenging activities. No mortality was observed in all groups. Rats in the cisplatin group were weak and less active compared to Polygonum minus treated rats. In the cisplatin group, disorganised cellular layers of the cerebral cortex were observed whereas rats treated with low and mid doses of Polygonum minus extract had normal cerebral cortex as in the control group. Mild ultrastructural changes were observed in rats treated with low and mid doses of Polygonum minus extract. Meanwhile, low and mid doses of Polygonum minus extract significantly reduced malondialdehyde level whereas low and mid doses of Polygonum minus extracts groups significantly increased catalase activity compared to the cisplatin group. Conclusions: Polygonum minus ethanolic extract at 100 and 200 mg/kg attenuates cisplatininduced oxidative stress in the cerebral cortex via its antioxidant activity. 
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This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. wet areas near river banks, drains and lakes. It also grows well on high hills and cool areas [3] . It has been traditionally used as an alternative medicine to treat indigestion, kidney stones, rheumatism and hair dandruff problem [2, 3] . It has large medical spectrum and possesses medicinal values including antioxidant, antiulcer, antiinflammatory, anticancer, antimicrobial and antiviral activities [4] .
The compounds attributed to its medicinal properties are flavonoid, terpenoid, alkaloids, coumarins and tannins [5, 6] . Due to its medicinal properties especially antioxidant, Pm is considered as a natural medicinal source.
Cisplatin (cis-diamminedichloroplatinum 栻 , CP) is the first platinum-based chemotherapeutic drug [7] which is effective for various human cancers such as lung, testicular, cervical, ovarian and head and neck cancers [8, 9] . However, during CP treatment, the patients might suffer from its severe adverse effects such as nephrotoxicity, hepatotoxicity, and neurotoxicity [10] . CP-induced central nervous system toxicity had been least studied compared to CP-induced peripheral neurotoxicity. During chemotherapy, CP is intended to destroy cancerous cells; however, non-cancerous (normal and healthy) cells are also being attacked by CP. It does not have a selective effect on cancer cells. Therefore, drug-induced toxicities are the main concern in CP chemotherapy. CP-induced toxicity is dose-dependent where CP accumulation in the affected organs triggers prominent necrotic changes [11] .
The mechanism of action of CP-induced neurotoxicity is uncertain; however, previous studies showed that oxidative stress (OS) due to overproduction of reactive oxygen species (ROS), high level of lipid peroxidation and decrease in the activity of antioxidant defence enzymes are the main causes of CP-induced neurotoxicity [12] [13] [14] .
Increased level of malondialdehyde (MDA) and reduced catalase (CAT) level were observed in CP-induced neurotoxicity [15] . Other possible mechanisms of CP-induced neurotoxicity are inflammation, DNA damage and apoptotic cell death in the nervous system [15] .
These changes can alter neuronal function, and cause nerve degeneration and loss of axons.
To the best of our knowledge, limited research had been performed on effect of Pm extract against CP-induced neurotoxicity or on its cognitive enhancing effect [16] . Thus, Pm was chosen in the present study against cisplatin-induced neurotoxicity. Given the anti-oxidant property of Pm, it is of high importance for treating the CP-induced neurotoxicity. This study will enlighten the beneficial effect of Pm and will be useful for the development of pharmaceutical products which are able to reduce the CP-induced central neurotoxicity.
Materials and methods

Chemicals and reagents
CP was purchased from Cayman Chemical ® (Ann Arbor, MI, USA). All chemicals and reagents used in this study were of analytical grades. The leaves were air-dried at room temperature for two weeks free of direct sunlight. Dried leaves were processed to powdered-form using a commercial grinder. Pm powder was soaked in a mixture of ethanol: water (70:30) solvent for 72 h and was filtered using
Plant collection and extraction of Pm ethanolic extract
Whatman™ filtered paper Number 1. The extraction process was repeated three times to fully extract the potential compounds from the plant. The collected filtrate was dried using Eyela N-1000 ® rotary evaporator at 50 曟 to obtain the ethanolic extract. The evaporation method was performed 4 to 5 times to acquire the ethanol-free concentrated ethanolic extract. Lastly, the extract was freeze-dried for easy-dilution preparation and administration to the rats via oral gavage.
In vitro antioxidant test
Total phenolic content (TPC) assay
TPC was determined using Folin-Ciocalteu reagent based on the method of Ahmad et al [2] by using gallic acid as a standard. Briefly, 0.2 mL of ethanolic solution of extract (1 mg/mL) and 1.5 mL of 10% Folin-Ciocalteu reagent were dissolved in water. The mixture was allowed to equilibrate for 5 min and then mixed with 1.5 mL of 6% natrium carbonate solution. After 90 min incubation at room temperature in the dark, the absorbance of the mixture was read at 725 nm using a spectrophotometer. The blank was prepared with ethanol solvent. All sample and control procedures were measured in triplicate and mean absorbance was obtained. TPC was calculated as mg of gallic acid equivalent per gram of extract (mg GAE/g of extract) using an equation obtained from the standard gallic acid calibration graph.
1-1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging assay
The principle of the test is to detect the ability of extract to reduce DPPH free radicals. The method was performed according to the method by Ahmad et al [2] . Briefly, DPPH was 
General observation of the rats
Body weight, signs of illness, daily activity and mortality were observed at least once daily throughout the experimental period.
Histological analysis
For histological analysis, the brain was collected, rinsed in cold saline and immediately fixed in freshly prepared 10% neutral buffered formalin for 48 h. The samples were dehydrated in ascending alcohol series and embedded in paraffin wax block.
Coronal sections of brain tissue (4 µm thickness) were cut with a microtome and stained with haematoxylin and eosin (H&E 
Ultrastructural analysis
The anterior part of the right hemisphere of the brain was cut in 1 mm 3 size by using an ultra diamond knife and fixed in 3% 
Measurement of lipid peroxidation
Lipid peroxidation was determined by measuring the MDA levels.
The brain tissues (10 mg) were lysed in 300 µL MDA lysis buffer and homogenized on ice. The mixtures were centrifuged at 13 000伊g for 10 min and the supernatant was collected for analysis.
In accordance with the protocol of Lipid Peroxidation (MDA)
Colorimetric/Fluorometric Assay Kit (BioVision, Cat No: K739-100, CA, USA), the standard was prepared. TBA reagent (600 µL) was added to all wells containing the standards and the samples. The plate was incubated at 95 曟 for 60 min followed by cooling to room temperature in an ice bath for 10 min. The absorbance was read at 532 nm using an ELISA plate reader. was added into the wells and incubated for 10 min. Finally, 10 µL of catalase potassium periodate was added and incubation was continued for another 5 min. The absorbance for the plate was read at 540 nm using a plate reader. CAT levels were calculated from the standard calibration curve and expressed as nmol/min/mL.
Measurement of brain CAT levels
Statistical analysis
All values were expressed as mean ± standard error of the mean (SEM). Differences among means were analysed using one-way ANOVA, followed by Tukey's post-hoc test. Statistical significance was considered at P<0.05. All computations were performed using SPSS software package version 24.
Results
Yield of Pm ethanolic extract
Total yield of Pm ethanolic extract collected from 800 g of wet weight of Pm leaves was 78.7 g. It is approximately about 10% of the initial weight of Pm leaves.
Antioxidant activities of Pm
The ethanolic extract of Pm contained high phenolic content [(977.6 ± 42.0) mg GAE/g of extract]. The DPPH scavenging activity of the Pm ethanolic extract showed (95.9 ± 1.9)% which was considered as high activity.
General observation results
No mortality was observed in all groups throughout the experiment.
Although behavioural tests have not been used, our daily observations of treated animals showed less activity and reduced alertness compared to the control and Pm treated groups. The body weight was significantly reduced in the CP, PmL and PmM compared to the control group (P<0.05) (Figure 1 ). The brain weight showed no significant difference (data not shown). 
Histopathological changes in brain
Control group showed features of normal cellular structures of cerebral cortex (Figure 2A ). In the cerebral cortex of the control group, neurons including pyramidal cells (blue arrows) and neuroglial cells were clearly identified. However, in the CP group, disorganized layers of cerebral cortex and increased cell population (yellow arrows) were observed ( Figure 2B ). The PmL ( Figure   2C ) and PmM ( Figure 2D ) groups showed similar features as in the control group. We also observed increased cell population and cellular derangement in PmH group ( Figure 2E ).
Ultrastructure changes of neurons
Neurons in control group exhibited large, round nucleus with uniformly distributed chromatins. The nuclear membrane was smooth and clear, and various organelles were finely arranged around the nucleus. The mitochondria and endoplasmic reticulum were intact with abundant ribosomes ( Figure 3A) . However, the CP group exhibited poorly defined irregular nuclear membranes and mitochondrial swelling with ruptured cristae, broken rough endoplasmic reticulum and unidentified ribosomes ( Figure 3B ).
The PmL ( Figure 3C ) and PmM ( Figure 3D ) groups showed a round nucleus with uniformly distributed chromatins. The nuclear membrane was smooth and clear. In Group PmH ( Figure 3E ), the nucleus was intact with unclear appearance of surrounding organelles. 
Brain MDA and CAT levels
Discussion
CP-induced neurotoxicity is one of the adverse effects following CP administration. There are less studies on CP-induced central nervous system toxicity compared to CP-induced peripheral neurotoxicity.
Till date, to the best of our knowledge, no specific treatment has been developed and limited study has been conducted on Pm in order to prevent CP-induced neurotoxicity. Thus, the present study aimed to investigate the protective effects of Pm ethanolic extract against CP-induced OS in the brain. One possible way to reduce OS is by supplementing the exogenous antioxidant. The plants are natural sources of antioxidants. The plant with higher levels of phenolic compounds has higher antioxidant activity which becomes a good candidate in prevention of OS-induced cell injury [17] .
CP elicits neurotoxic effect in treating cancer patients. Its therapeutic dose needs to be adjusted or the treatment cycle should be stopped when the toxicity occurs. Peripheral neuropathy is more common than that of the central nervous system (CNS). It could be due to the function of blood-brain-barrier in CNS which prevents the entry of CP to reduce the exposure to nervous tissue [18] . However, the CNS toxicity does occur even within the recommended dose [19] . This might be owing to the direct toxic effect of CP or the consequences of electrolytes imbalance [20] . The signs of CNS toxicity are ranging from cognitive impairment to unconsciousness [21] .
The postulated mechanism of CNS toxicity is OS [14, 15] . The mitochondria of the CP-exposed cells either normal or cancerous cells are the source of production of ROS [20] . The ROS has a high affinity to bind the cell membrane lipid and subsequently cause lipid peroxidation. The MDA is one of the end products of lipid peroxidation. Excessive formation of ROS causes depletion of innate antioxidants, leading to OS [22] . Our findings on MDA and CAT suggest that the cells in the brain exposed to CP succumb to OS. CP causes OS by generating ROS which can alter normal cell physiology [23, 24] . This is due to the brain consumes more than 20% of the oxygen utilized by the other organs during the mitochondrial respiration, it possesses high probability to be challenged by ROS compared to other tissues. Moreover, brain neurotransmitter also autoxidized and produced their own ROS, thus automatically increased the generation of the ROS in the brain [14] . In the present study, the highest OS level was observed in the CP group without the Pm supplementation. The nervous tissue is most sensitive against OS because it contains abundant polyunsaturated fatty acids which are highly susceptible to the lipid peroxidation [25] . The ROS such as superoxide and hydrogen peroxide are broken down by innate antioxidant enzymes, SOD and CAT, respectively. The CAT is one of the supportive enzyme systems among superoxide dismutase and glutathione peroxidase which act as the first line cellular defence against ROS by decomposing O 2 and H 2 O 2 prior to the formation of more harmful hydroxyl and alkoxyl radicals. Excessive formation of ROS causes depletion of innate antioxidants, leading to OS [26] . MDA reacts with nucleic acid bases that impair the normal cell function.
These findings proved that even short administration of CP formed ROS, imbalanced the ROS and antioxidant defence system which Pm with a high level of phenolic compounds has higher antioxidant activity which becomes a good candidate in prevention of OSinduced cell injury [26] . The Pm ethanolic extract used in the present study has high total phenolic contents and was able to attribute the 96% reduction of DPPH free radicals. However, further detailed analysis of compounds present in the Pm extract is recommended to determine the exact mechanism of protection. In the literature, the phenolic acids, flavonoids and non-flavonoids compounds comprise in the total phenolic contents and these compounds exhibit antioxidant activity [17] . The flavonoids that normally attribute this activity are gallic acid, rutin, quercetin and coumaric acid [27] , which are soluble based on the polarity, thus the compounds are able to pass through the blood brain barrier [28] .
The mechanism of reduction of OS by the phenolic compound passes via removal of free radicals or by reduction of hydroperoxides.
However, the removal of these radicals is unlikely to happen in vivo, thus one of the postulated protective mechanisms is to prevent the formation of these radicals by stimulating the endogenous antioxidant system via nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (Keap 1) signalling pathway [29] . Our finding suggested that the phenolic contents of Pm prevented the formation of free radicals as lipid peroxidation was reduced and the endogenous antioxidant enzyme activity remained the same as in the control group. This could be owing to the properties of phenolic compounds of Pm such as hydrogen donating ability, ability to interrupt lipid peroxidation and ability to act as a metal chelator [27] . Further investigation is required to understand the exact mechanism of protection by Pm.
Throughout the alteration of metabolism of the brain, CP indirectly impaired the brain morphology. In the present study, CP produced microscopic alterations to the brain cells. Dark pyknotic nuclei were also observed in the CP group which was similar to the finding by Moneim [14] . The present findings demonstrated that alteration in brain morphology might be due to the accumulation of platinum compound in the cerebral cortex layers, thus leading to high levels of platinum-DNA binding in the cerebral layers. It is postulated that CP caused damage in brain vasculature, interfered integrity of blood brain barrier, and disturbed brain homeostasis, leading to damaging cerebral neurons and surrounding organelles [25] . The histological and ultrastructural findings in our study showed that the protective effect of Pm was only observed at low (100 mg/kg) and medium dose (200 mg/kg) whereas the high dose (400 mg/kg) showed a detrimental effect. This effect could be explained by the facts that the high dose consumption of phenolic compound produced the paradoxical effect because the proxidants, such as semiquinones and quinones are formed due to interaction between the phenolic compounds and metal ions [17, 29] . Therefore, the supplementation of high dose of Pm extract should be cautious as it might produce the unwanted effect.
In conclusion, the present study suggested that OS is the main concern in CP-induced neurotoxicity. However, the supplementation of Pm extract with low and medium doses prevented the CP-induced neurotoxicity in rats without interfering with antitumour efficacy of CP. The protective effect is due to antioxidant property of Pm which prevents the formation of free radicals. Further dose adjustment and calculation are needed for the human usage.
